Home

Blake Borgeson, Director: Recursion Pharmaceuticals RXRX Sell · Filed 23/05/17

Trade details

Type
Insider sale
Amount
$45,224.65
Shares · price
8,885 sh · $5.09 a share
Held after
7,549,632 sh
Trade date
23/05/16
Filed
23/05/17
Days to filing
1 days

Sold 0.1% of holdings

Share of holding sold
0.1%

Recursion Pharmaceuticals trades, last 26 weeks

What else happened in Recursion Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/04/16~23/06/15

Blake Borgeson's recent trades

  • Blake Borgeson

    Planned sale10b5-1 planRecursion Pharmaceuticals

    $100.2K

    Filed 09/01

  • Blake Borgeson

    Planned sale10b5-1 planRecursion Pharmaceuticals

    $97.5K

    Filed 08/04

  • Blake Borgeson

    Planned sale10b5-1 planRecursion Pharmaceuticals

    $158.5K

    Filed 07/07

  • Blake Borgeson

    Sell10b5-1 planRecursion Pharmaceuticals

    $110.4K

    Filed 06/04

  • Blake Borgeson

    Planned sale10b5-1 planRecursion Pharmaceuticals

    $110.4K

    Filed 06/02